​

TransCode Therapeutics (RNAZ) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

TransCode Therapeutics Revenue Highlights

00

TransCode Therapeutics Revenue by Period

TransCode Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

TransCode Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

TransCode Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$753.15K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--

TransCode Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

TransCode Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
XBIOXenetic Biosciences$2.54M$614.24K
SONNSonnet BioTherapeutics$147.81K-
EYENEyenovia$3.79K$1.63K
CNSPCNS Pharmaceuticals--
ZURAZura Bio--
REVBRevelation Biosciences--
CGTXCognition Therapeutics--
PHIOPhio Pharmaceuticals--
ZVSAZyVersa Therapeutics--
KODKodiak Sciences--
IMMXImmix Biopharma--
RNAZTransCode Therapeutics--

RNAZ Revenue FAQ

What is TransCode Therapeutics’s yearly revenue?

TransCode Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RNAZ's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is TransCode Therapeutics’s quarterly revenue?

TransCode Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). RNAZ's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is TransCode Therapeutics’s revenue growth rate?

TransCode Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.